Biohaven (BHVN) Enterprise Value (2021 - 2026)
Biohaven (BHVN) reported Enterprise Value of -$347.8 million for Q1 2026, down 7.77% on a YoY basis from -$377.1 million in Q1 2025, and down 8.99% sequentially from -$319.1 million in Q4 2025.
Biohaven (BHVN) Enterprise Value (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Enterprise Value data on file, last reported at -$347.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 7.77% year-over-year to -$347.8 million; the trailing twelve-month figure through Mar 2026 stood at -$347.8 million (down 7.77% YoY), and the FY2025 full-year result was -$319.1 million, up 34.33% from the prior year.
- Enterprise Value fell to -$347.8 million in Q1 2026, from -$319.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$23.2 million in Q2 2022 to a low of -$486.0 million in Q4 2024.
- A 5-year average of -$275.7 million and a median of -$319.1 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 85.99% in 2022, while the deepest fall reached 2798.06% in 2022.
- Tracing BHVN's Enterprise Value over 5 years: stood at -$465.3 million in 2022, then advanced by 17.95% to -$381.8 million in 2023, then fell by 27.28% to -$486.0 million in 2024, then surged by 34.33% to -$319.1 million in 2025, then dropped by 8.99% to -$347.8 million in 2026.
- Business Quant data shows BHVN's Enterprise Value at -$347.8 million in Q1 2026, -$319.1 million in Q4 2025, and -$260.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -347.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -347.82 Mn |
| Dec 31, 2025 | -319.14 Mn |
| Sep 30, 2025 | -260.22 Mn |
| Jun 30, 2025 | -404.98 Mn |
| Mar 31, 2025 | -322.75 Mn |
| Dec 31, 2024 | -485.99 Mn |
| Sep 30, 2024 | -378.82 Mn |
| Jun 30, 2024 | -436.95 Mn |
| Mar 31, 2024 | -283.42 Mn |
| Dec 31, 2023 | -381.82 Mn |
| Sep 30, 2023 | -111.73 Mn |
| Jun 30, 2023 | -188.03 Mn |
| Mar 31, 2023 | -186.58 Mn |
| Dec 31, 2022 | -465.34 Mn |
| Sep 30, 2022 | -50.67 Mn |
| Jun 30, 2022 | -23.21 Mn |
| Mar 31, 2022 | -40.26 Mn |
| Dec 31, 2021 | -16.06 Mn |
| Sep 30, 2021 | -361.70 Mn |